Eli Lilly said on Wednesday the U.S. health regulator has approved its drug to treat adults with moderate-to-severe Crohn's ...
The review, which was spurred by controversy over the FDA's Aduhelm approval, recommends two main changes in agency ...
In 2024, the General Assembly passed House Bill 11, which limits vape products that can be sold in Kentucky.
Zepbound is a dual-activating medication that combines glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like ...
A non-opioid painkiller from Vertex Pharmaceuticals could become a blockbuster, but questions remain on whether it will prove ...